Trastuzumab Deruxtecan‐Induced Pneumonitis: Case Series
ABSTRACT Trastuzumab deruxtecan (T‐DXd) is a HER2‐targeted antibody–drug conjugate with proven efficacy in metastatic breast cancer, but interstitial lung disease (ILD) and drug‐induced pneumonitis are potentially life‐threatening toxicities. We retrospectively reviewed three patients with HER2‐posi...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2026-03-01
|
| Serie: | Clinical Case Reports |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/ccr3.72168 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|